Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
C Cesana, C Klersy, L Barbarano, AM Nosari… - Journal of Clinical …, 2002 - ascopubs.org
PURPOSE: To evaluate the natural history of monoclonal gammopathy of undetermined
significance (MGUS) and smoldering multiple myeloma (SMM), identify early predictors of …
significance (MGUS) and smoldering multiple myeloma (SMM), identify early predictors of …
Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study
…, R Spanedda, A De Paoli, L Barbarano… - British Journal of …, 2000 - nature.com
We conducted a randomized trial to evaluate whether melphalan-prednisone (MPH-P)
treatment administered just after diagnosis improves survival of stage I multiple myeloma (MM). …
treatment administered just after diagnosis improves survival of stage I multiple myeloma (MM). …
Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients
…, M Ferrarese, GB Migliori, L Barbarano… - European …, 2006 - Eur Respiratory Soc
The aim of this study was to compare the performance of the T-SPOT.TB TM test, a T-cell-based
test, with the tuberculin skin test (TST) in the diagnosis of latent tuberculosis (TB) …
test, with the tuberculin skin test (TST) in the diagnosis of latent tuberculosis (TB) …
Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: definition and management of the risk related to zoledronic acid
AM Cafro, L Barbarano, AM Nosari, G D'Avanzo… - Clinical Lymphoma and …, 2008 - Elsevier
Purpose Bisphosphonates (BPs) are currently used to treat bone lesions in patients with
multiple myeloma (MM). Osteonecrosis of the jaw (ONJ) has been reported as an adverse event …
multiple myeloma (MM). Osteonecrosis of the jaw (ONJ) has been reported as an adverse event …
Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy
…, L Cavanna, B Canesi, E Tresoldi, L Barbarano… - Seminars in …, 2003 - Elsevier
… in WM and in other lymphoproliferative disorders, 20 its prognostic significance in both
WM and asymptomatic IgM-MG is still undefined.3, 5, 8, 9, 18 In our study, ALCs > 4 × 10 9 /L …
WM and asymptomatic IgM-MG is still undefined.3, 5, 8, 9, 18 In our study, ALCs > 4 × 10 9 /L …
Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders
…, C Klersy, L Barbarano, M Varettoni, L Cavanna… - Leukemia, 2004 - nature.com
We evaluated the prognostic features of 384 asymptomatic IgM-monoclonal gammopathies (aIgM-MGs)
and 74 IgM-related disorders (IgM-RDs), two clinically distinct groups as …
and 74 IgM-related disorders (IgM-RDs), two clinically distinct groups as …
DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) is an effective regimen for peripheral blood stem cell collection in multiple myeloma
M Lazzarino, A Corso, L Barbarano… - Bone marrow …, 2001 - nature.com
DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) has proved to be an
effective salvage therapy for refractory-relapsed MM patients. Little is known, however, about …
effective salvage therapy for refractory-relapsed MM patients. Little is known, however, about …
Treatment of multiple myeloma according to the extension of the disease: a prospective, randomised study comparing a less with a more aggressive cytostatic policy
…, O Mora, R Spanedda, A De Paoli, L Barbarano… - British journal of …, 1994 - nature.com
The purpose of the study was to ascertain whether the prognostic significance of staging in
multiple myeloma (MM) is influenced by the aggressiveness of effective induction treatment …
multiple myeloma (MM) is influenced by the aggressiveness of effective induction treatment …
Risk factors for the development of bacterial infections in multiple myeloma treated with two different vincristine-adriamycin-dexamethasone schedules
…, V Rossi, P Ferrando, M Valentini, L Barbarano… - …, 2003 - haematologica.org
BACKGROUND AND OBJECTIVES: We evaluated bacterial infections (BIs) in patients with
multiple myeloma (MM) treated with two different schedules of vincristine-adriamycin-…
multiple myeloma (MM) treated with two different schedules of vincristine-adriamycin-…
Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B …
…, P Marenco, E Tresoldi, L Barbarano… - Bone marrow …, 2002 - nature.com
The aim of our study was to evaluate the impact of an early intensification programme including
chemotherapy (CHT), autologous stem cell transplantation (ASCT) and radiation therapy …
chemotherapy (CHT), autologous stem cell transplantation (ASCT) and radiation therapy …